Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Infect Dev Ctries ; 7(9): 676-9, 2013 Sep 16.
Artigo em Inglês | MEDLINE | ID: mdl-24042104

RESUMO

INTRODUCTION: Diagnosing tuberculosis in low-resource settings mostly relies on sputum smear microscopy. Improvement through capacity building is a priority. This project aimed to strengthen tuberculosis diagnosis at an intermediate level laboratory. METHODOLOGY: The Italian National Institute for Infectious Diseases and the Italian Development Cooperation closely collaborated with regional and national institutions and reference laboratories to provide laboratory setup, equipment and reagents, personnel training, and the implementation of culture and quality assessment programs at Dodoma Regional Hospital, Dodoma, Tanzania. RESULTS: Microscopy sensitivity was increased, personnel were trained, and culture techniques and quality assessment programs were introduced. CONCLUSIONS: Implementing tuberculosis diagnosis in resource-constrained settings is feasible and represents a basis for further strengthening.


Assuntos
Serviços de Laboratório Clínico/organização & administração , Técnicas de Laboratório Clínico/métodos , Tuberculose/diagnóstico , Serviços de Laboratório Clínico/economia , Técnicas de Laboratório Clínico/economia , Países em Desenvolvimento , Humanos , Tanzânia
2.
Antimicrob Agents Chemother ; 54(4): 1616-8, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20086151

RESUMO

The new antitubercular drug candidate 2-[2-S-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one (BTZ043) targets the DprE1 (Rv3790) subunit of the enzyme decaprenylphosphoryl-beta-d-ribose 2'-epimerase. To monitor the potential development of benzothiazinone (BTZ) resistance, a total of 240 sensitive and multidrug-resistant Mycobacterium tuberculosis clinical isolates from four European hospitals were surveyed for the presence of mutations in the dprE1 gene and for BTZ susceptibility. All 240 strains were susceptible, thus establishing the baseline prior to the introduction of BTZ043 in clinical trials.


Assuntos
Antituberculosos/farmacologia , Mycobacterium tuberculosis/efeitos dos fármacos , Mycobacterium tuberculosis/isolamento & purificação , Compostos de Espiro/farmacologia , Tiazinas/farmacologia , Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico , Tuberculose Resistente a Múltiplos Medicamentos/microbiologia , Sequência de Bases , Primers do DNA/genética , DNA Bacteriano/genética , Farmacorresistência Bacteriana Múltipla/genética , Europa (Continente) , Genes Bacterianos , Humanos , Técnicas In Vitro , Testes de Sensibilidade Microbiana , Mutação , Mycobacterium tuberculosis/enzimologia , Mycobacterium tuberculosis/genética , Racemases e Epimerases/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...